Biotech Pluristem Reports Topline Results from its Phase III Study of Muscle Regeneration Following Hip Fracture Surgery July 25, 2022
Biotech Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 25, 2022
Biotech Vaxcyte Completes Enrollment of Phase 2 Portion of Phase 1/2 Clinical Proof-of-Concept Study Evaluating Safety, Tolerability and Immunogenicity of VAX-24 in Adults July 25, 2022
Biotech The GBT Foundation Awards $250,000 in ACE Grants to Support Sickle Cell Disease Community-Based Organizations July 25, 2022
Biotech Agios to Webcast Conference Call of Second Quarter 2022 Financial Results on August 4, 2022 July 25, 2022
Gaming Live Current Signs New Marketing Agreement with Think Ink Marketing and Engages Alliance Equity Capital Group July 25, 2022
Search
press release
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
July 25, 2022
